Table 2.
Prevalences of severe fatigue in neuromuscular disorders
| Neuromuscular disorder | Prevalence of severe fatigue (%) | Fatigue scale used to assess severity of fatigue |
|---|---|---|
| Guillain-Barré syndrome [28, 38, 64, 78] | 38–86 | FSS, FIS, VAS-F |
| Pompe disease [40] | 67 | FSS |
| Myasthenia gravis [71] | 82 | FIS, MFI |
| Post-poliomyelitis syndrome [53] | 80 | NA |
| Facioscapulohumural dystrophy [48, 81] | 51–61 | CIS |
| Myotonic dystrophy [48, 81] | 53–74 | CIS |
| Charcot-Marie-Tooth disease type 1 (CMT type 1) [48, 81] | 55–64 | CIS |
CIS checklist individual strength, FIS fatigue impact scale, FSS fatigue severity scale, MFI multidimensional fatigue inventory, VAS-F visual analogue scale for fatigue, NA not applicable